Αρχική World News Study Finds the Cost of Treating Metastatic Breast Cancer Could More Than...

Study Finds the Cost of Treating Metastatic Breast Cancer Could More Than Double by 2030

A cancer diagnosis impacts your mental health, your physical health, and your financial health. For metastatic breast cancer patients, the bills can be overwhelming, with studies showing this is especially true for women under the age of 45. New research says these costs will continue to climb.

A team at the University of North Carolina Center for Health Promotion and Disease Prevention created a model to project the number of metastatic breast cancer patients in the U.S. by 2030, along with the costs they’ll incur to treat the disease. They estimated that by 2030, the collective cost will more than $150 billion annually. That’s more than double 2015 numbers. The findings were published in JNCI Cancer Spectrum.

PHOTO: ADOBE STOCK/WATERCOLOR_CONCEPT

The study explains, “The cost of metastatic breast cancer could increase substantially in the coming decade, especially among younger and midlife women. “

To determine how costs would rise, the team used data from the U.S. Census and the National Cancer Institute. They estimated that there will be 246,194 women living with metastatic breast cancer in 2030. That’s 54.8% higher than 2015 figures.

They then worked on projecting how costs could change. To do that, they estimated both medical costs and productivity costs. The latter includes lost workdays while living with cancer and productive years that are lost when women die of the disease. Taking these into consideration, along with the projected uptick in diagnoses, they estimate that the collective annual cost will be $152.4 billion in 2030. That’s compared with $63.4 billion in 2015.

PHOTO: ADOBE STOCK/OBEYLEESIN

The authors say that this increase will especially be felt by younger women battling the disease, as case rates in this age group continue to rise.

Dr. Justin Trogdon, study author and research fellow at the UNC Center for Health Promotion and Disease Prevention, explains, “For metastatic breast cancer, it is not just the ‘silver tsunami’ of aging baby boomers that will increase the demands on our care system. We should also be prepared for an increase in younger women requiring treatment and services for metastatic disease.”

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

The authors say that to address these issues, it may be helpful for policymakers to invest more in early detection of breast cancer and in treatment. They did not try to forecast any technological and treatment advances that may arise over the coming decade, so those may help, as well.

Dr. Stephanie Wheeler, co-author and professor of health policy and management at UNC, says, “Importantly, treatment and technological advances or major health care delivery reforms could begin to ‘bend the curve’ of unrestrained cost growth in metastatic cancer — with potentially the greatest impact among young and midlife women who stand to lose the most if medical and policy innovations are not aggressively pursued.”

If you’d like to help address some of the costs associated with breast cancer and lessen the likelihood of a woman developing metastatic breast cancer, sign this petition to ensure insurance companies cover tests for genetic markers like BRCA.

PHOTO: ADOBE STOCK/SUPACHAI

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...